Document is current
Any future updates will be listed below
-
Authors
Lebeer, Sarah http://orcid.org/0000-0002-9400-6918
Ahannach, Sarah http://orcid.org/0000-0002-8274-5342
Gehrmann, Thies http://orcid.org/0000-0003-4666-5406
Wittouck, Stijn http://orcid.org/0000-0003-3913-5677
Eilers, Tom http://orcid.org/0000-0002-7509-2902
Oerlemans, Eline
Condori, Sandra http://orcid.org/0000-0002-9494-6336
Dillen, Jelle http://orcid.org/0000-0003-4160-7645
Spacova, Irina http://orcid.org/0000-0003-0562-7489
Vander Donck, Leonore
Masquillier, Caroline
Allonsius, Camille Nina http://orcid.org/0000-0003-2599-9941
Bron, Peter A. http://orcid.org/0009-0000-5436-5126
Van Beeck, Wannes http://orcid.org/0000-0003-0421-8931
De Backer, Charlotte
Donders, Gilbert
Verhoeven, Veronique http://orcid.org/0000-0002-3708-6501
- License Information
-
More Information
Article History
Received: 17 February 2022
Accepted: 13 September 2023
First Online: 26 October 2023
Competing interests
: S.L. declares to be a voluntary academic board member of the International Scientific Association on Probiotics and Prebiotics (ISAPP,), cofounder of YUN and scientific advisor for Freya Biosciences. She declares research funding from YUN, Bioorg, Puratos, DSM I-Health and Lesaffre/Gnosis. P.A.B. is an independent consultant for several companies in the food and pharmaceutical industry bound by confidentiality agreements. G.D. is the chairperson of Femicare vzw () and has worked as a medical consultant for various industries. None of these organizations or companies was involved in the design, communication or data analysis of this Isala study, which was fully funded by university, governmental and European funding, with the largest part funded by the European Research Council Starting Grant (ERC StG) project Lacto-Be. The other authors declare no competing interests.
